ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,446.00
      2.17%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      82.765
      0.00%
      Bitcoin
      63,182.93
      0.47%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. ZyVersa Therapeutics Inc (ZVSA)

      7. ZyVersa Therapeutics Inc (ZVSA) News

      ZVSA ZyVersa Therapeutics Inc

      5.48
      -0.26 (-4.53%)
      May 03 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      ZyVersa Therapeutics Inc ZVSA NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      -0.26 -4.53% 5.48 20:00:00
      Open Price Low Price High Price Close Price Prev Close
      5.58 5.2501 6.00 5.45 5.74
      more quote information »

      Recent News

      Date Time Source Heading
      4/29/202407:57GLOBEZyVersa Therapeutics Announces Publication Reinforcing the..
      4/04/202407:57GLOBEZyVersa Therapeutics Highlights Published Data Demonstrating..
      3/25/202408:17GLOBEZyVersa Therapeutics Reports Full Year 2023 Financial..
      3/18/202407:57GLOBEZyVersa Therapeutics Announces IRB Approval of Phase 2a..
      3/14/202407:57GLOBEZyVersa Therapeutics' CEO, Stephen C. Glover to Participate..
      3/08/202417:00EDGAR2Form 8-K - Current report
      3/08/202417:00EDGAR2Form PRE 14A - Other preliminary proxy statements
      2/29/202407:57GLOBEZyVersa Therapeutics Generated Approximately $2.7 Million..
      2/28/202407:57GLOBEZyVersa Therapeutics Highlights Data from Review Article..
      2/22/202407:47GLOBEZyVersa Therapeutics Publishes New White Paper Detailing the..
      2/14/202416:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
      2/14/202407:53GLOBEZyVersa Therapeutics Highlights Review Article..
      2/07/202408:02GLOBEZyVersa Therapeutics' CEO, Stephen C. Glover to Present at..
      1/31/202407:57GLOBEZyVersa Therapeutics Highlights Publication Indicating That..
      1/24/202407:57GLOBEZyVersa Therapeutics Announces Peer-Reviewed Article..
      1/19/202406:19EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      1/17/202407:52GLOBEZyVersa Therapeutics Highlights Peer-Reviewed Article..
      1/10/202408:06GLOBEZyVersa Therapeutics’ CEO, Stephen C. Glover, Featured on..
      1/04/202407:50GLOBEZyVersa Therapeutics Announces Equity Research Coverage..
      1/03/202408:07GLOBEZyVersa Therapeutics CEO, Stephen C. Glover, Issues Letter..
      12/22/202316:45EDGAR2Form 8-K - Current report
      12/18/202308:12GLOBEZyVersa Therapeutics’ CEO, Stephen C. Glover, to Participate..
      12/14/202307:01GLOBEZyVersa Therapeutics Engages CRO, George Clinical, for Phase..
      12/11/202316:30EDGAR2Form 8-K - Current report
      12/08/202316:44EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
      12/07/202311:20GLOBEZyVersa Therapeutics Announces Publication Demonstrating..
      12/07/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
      12/06/202321:00GLOBEZyVersa Therapeutics, Inc. Announces Pricing of $5.0 Million..
      12/06/202307:20GLOBEZyVersa Therapeutics Announces Publication Showing AIM2 and..
      11/30/202311:45EDGAR2Form 8-K - Current report
      11/30/202311:30GLOBEZyVersa Therapeutics, Inc. Announces Reverse Stock Split and..
      11/20/202317:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      11/17/202316:15EDGAR2Form 8-K - Current report
      11/14/202316:35GLOBEZyVersa Therapeutics Reports Third Quarter 2023 Corporate..
      11/09/202307:35GLOBEZyVersa Therapeutics Announces Article Published in..
      11/06/202307:05GLOBEZyVersa Therapeutics Announces Article in Peer-Reviewed..
      11/02/202316:37EDGAR2Form 8-K - Current report
      11/01/202308:07GLOBEZyVersa Therapeutics Announces Publication in Molecular..
      10/25/202306:50GLOBEZyVersa Therapeutics Announces Research Published in the..
      10/24/202316:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      10/18/202307:05GLOBEZyVersa Therapeutics Announces a Publication in the..
      10/17/202316:15EDGAR2Form S-1/A - General form for registration of securities..
      10/11/202307:05GLOBEZyVersa Therapeutics Announces Peer-Reviewed Publication in..
      10/04/202307:05GLOBEZyVersa Therapeutics Announces New Peer-Reviewed Publication..
      9/27/202307:07GLOBEZyVersa Therapeutics' CEO, Stephen C. Glover to Participate..
      9/22/202306:35GLOBEZyVersa Therapeutics Announces Research Published in The..
      9/20/202317:15EDGAR2Form 8-K/A - Current report: [Amend]
      9/14/202307:00EDGAR2Form 8-K - Current report
      9/13/202316:57EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      9/13/202316:40EDGAR2Form DEF 14A - Other definitive proxy statements

      Your Recent History

      NASDAQ
      ZVSA
      ZyVersa Therapeutics
      Delayed Upgrade Clock